Medpark Hosts Its First Financing Event in October, Showcasing Innovations from Five MedTech Startups

Oct 17, 2025 16:45 CST Updated 16:45

Medpark

Bone Graft Material Developer

Venmedtech

Peripheral Vascular Field Product R&D and Manufacturer

viestar

Precision Optical Biopsy Technology R&D and Manufacturer

On October 17, Medpark's first investment and financing meeting in October was successfully held at the accelerator of Jiangsu Medical Device Technology Park. Following the concept of "precise matchmaking and efficient empowerment," this event built a face-to-face communication bridge for outstanding companies and financial institutions within the park.

During the roadshow session, five companies—Avivid Biotech, Insifeiying, Venmedtech, Viestar, and Suzhou GK Medtech Science and Technology Development (Group) Co., Ltd.—took the stage in sequence to showcase their core technological achievements and innovative solutions.

Avivid Bio is an innovative technology company that focuses on providing human organ chip products and solutions; Inseifly specializes in the innovation and application of wireless and intelligent medical technologies, offering more efficient and convenient surgical solutions for clinical use; Venmedtech is a comprehensive medical device platform dedicated to endovascular treatments for venous diseases; Viestar is committed to providing advanced technologies with clinical value for the early precise diagnosis and treatment of tumors; Suzhou GK Medtech Science and Technology Development (Group) Co., Ltd. concentrates on the technical development and commercialization of medical instruments and biopharmaceuticals, having launched multiple proprietary products across various fields.

Representatives from Guoqian Capital, Sushuke Capital, Suzhou New District Sci-Tech Angel Fund, Jiangsu Bank, and other institutions were invited to attend the conference. They engaged in in-depth discussions with enterprises on topics such as technical pathways, clinical applications, and market prospects.

Medpark will continue to build a normalized investment and financing service system, accurately connecting industry with capital, promoting the accelerated growth of innovative projects, and assisting enterprises in achieving high-quality development.